Xilis, Inc. is an innovative biotech company based in Research Triangle Park, Durham, NC, focused on advancing precision oncology through its proprietary MicroOrganoSphere (MOS) Technology. This cutting-edge technology allows for the rapid and scalable creation of patient-specific tumor models that accurately reflect individual tumor biology and microenvironments, making it a pivotal tool for drug discovery and development in precision oncology. Xilis is dedicated to building a comprehensive functional precision medicine platform that integrates multi-modal profiling and AI/ML analytics to enhance drug discovery, development, and diagnostics. The company's mission is to leverage its MOS Platform to develop effective therapeutics and ensure they reach the appropriate patients at the right time.